Showing 1 - 1 results of 1 for search 'Eva Falk', query time: 0.02s Refine Results
  1. 1
    Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting.

    Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. by Anders Svenningsson, Eva Falk, Elisabeth G Celius, Siegrid Fuchs, Karen Schreiber, Sara Berkö, Jennifer Sun, Iris-Katharina Penner, Tynergy Trial Investigators

    Published 2013-01-01
    Get full text
    Article

Search Tools: